Table of Content

1 Dalfampridine Market Overview
1.1 Product Overview and Scope of Dalfampridine
1.2 Dalfampridine Segment by Type
1.2.1 Global Dalfampridine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 10 mg
1.2.3 Others
1.3 Dalfampridine Segment by Application
1.3.1 Dalfampridine Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Dalfampridine Market Size Estimates and Forecasts
1.4.1 Global Dalfampridine Revenue 2016-2027
1.4.2 Global Dalfampridine Sales 2016-2027
1.4.3 Dalfampridine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Dalfampridine Market Competition by Manufacturers
2.1 Global Dalfampridine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dalfampridine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dalfampridine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dalfampridine Manufacturing Sites, Area Served, Product Type
2.5 Dalfampridine Market Competitive Situation and Trends
2.5.1 Dalfampridine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dalfampridine Players Market Share by Revenue
2.5.3 Global Dalfampridine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dalfampridine Retrospective Market Scenario by Region
3.1 Global Dalfampridine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Dalfampridine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Dalfampridine Market Facts & Figures by Country
3.3.1 North America Dalfampridine Sales by Country
3.3.2 North America Dalfampridine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dalfampridine Market Facts & Figures by Country
3.4.1 Europe Dalfampridine Sales by Country
3.4.2 Europe Dalfampridine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dalfampridine Market Facts & Figures by Region
3.5.1 Asia Pacific Dalfampridine Sales by Region
3.5.2 Asia Pacific Dalfampridine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dalfampridine Market Facts & Figures by Country
3.6.1 Latin America Dalfampridine Sales by Country
3.6.2 Latin America Dalfampridine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dalfampridine Market Facts & Figures by Country
3.7.1 Middle East and Africa Dalfampridine Sales by Country
3.7.2 Middle East and Africa Dalfampridine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Dalfampridine Historic Market Analysis by Type
4.1 Global Dalfampridine Sales Market Share by Type (2016-2021)
4.2 Global Dalfampridine Revenue Market Share by Type (2016-2021)
4.3 Global Dalfampridine Price by Type (2016-2021)

5 Global Dalfampridine Historic Market Analysis by Application
5.1 Global Dalfampridine Sales Market Share by Application (2016-2021)
5.2 Global Dalfampridine Revenue Market Share by Application (2016-2021)
5.3 Global Dalfampridine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Acorda Therapeutics
6.1.1 Acorda Therapeutics Corporation Information
6.1.2 Acorda Therapeutics Description and Business Overview
6.1.3 Acorda Therapeutics Dalfampridine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Acorda Therapeutics Product Portfolio
6.1.5 Acorda Therapeutics Recent Developments/Updates
6.2 Elan Pharma
6.2.1 Elan Pharma Corporation Information
6.2.2 Elan Pharma Description and Business Overview
6.2.3 Elan Pharma Dalfampridine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Elan Pharma Product Portfolio
6.2.5 Elan Pharma Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Dalfampridine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biogen Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Corporation Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Dalfampridine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharmaceutical Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Dalfampridine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Aurobindo Pharma Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates

7 Dalfampridine Manufacturing Cost Analysis
7.1 Dalfampridine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dalfampridine
7.4 Dalfampridine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dalfampridine Distributors List
8.3 Dalfampridine Customers

9 Dalfampridine Market Dynamics
9.1 Dalfampridine Industry Trends
9.2 Dalfampridine Growth Drivers
9.3 Dalfampridine Market Challenges
9.4 Dalfampridine Market Restraints

10 Global Market Forecast
10.1 Dalfampridine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dalfampridine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dalfampridine by Type (2022-2027)
10.2 Dalfampridine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dalfampridine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dalfampridine by Application (2022-2027)
10.3 Dalfampridine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dalfampridine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dalfampridine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dalfampridine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dalfampridine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Dalfampridine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dalfampridine Covered in This Study
Table 5. Global Dalfampridine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Dalfampridine Sales Share by Manufacturers (2016-2021)
Table 7. Global Dalfampridine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dalfampridine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dalfampridine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dalfampridine Manufacturing Sites and Area Served
Table 11. Manufacturers Dalfampridine Product Type
Table 12. Global Dalfampridine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dalfampridine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dalfampridine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dalfampridine Sales by Region (2016-2021) & (K Units)
Table 16. Global Dalfampridine Sales Market Share by Region (2016-2021)
Table 17. Global Dalfampridine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 19. North America Dalfampridine Sales Market Share by Country (2016-2021)
Table 20. North America Dalfampridine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dalfampridine Revenue Market Share by Country (2016-2021)
Table 22. Europe Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Dalfampridine Sales Market Share by Country (2016-2021)
Table 24. Europe Dalfampridine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dalfampridine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dalfampridine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Dalfampridine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dalfampridine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dalfampridine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Dalfampridine Sales Market Share by Country (2016-2021)
Table 32. Latin America Dalfampridine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dalfampridine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dalfampridine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Dalfampridine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dalfampridine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dalfampridine Revenue Market Share by Country (2016-2021)
Table 38. Global Dalfampridine Sales (K Units) by Type (2016-2021)
Table 39. Global Dalfampridine Sales Market Share by Type (2016-2021)
Table 40. Global Dalfampridine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dalfampridine Revenue Share by Type (2016-2021)
Table 42. Global Dalfampridine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Dalfampridine Sales (K Units) by Application (2016-2021)
Table 44. Global Dalfampridine Sales Market Share by Application (2016-2021)
Table 45. Global Dalfampridine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dalfampridine Revenue Share by Application (2016-2021)
Table 47. Global Dalfampridine Price (US$/Unit) by Application (2016-2021)
Table 48. Acorda Therapeutics Corporation Information
Table 49. Acorda Therapeutics Description and Business Overview
Table 50. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Acorda Therapeutics Dalfampridine Product
Table 52. Acorda Therapeutics Recent Developments/Updates
Table 53. Elan Pharma Corporation Information
Table 54. Elan Pharma Description and Business Overview
Table 55. Elan Pharma Dalfampridine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Elan Pharma Dalfampridine Product
Table 57. Elan Pharma Recent Developments/Updates
Table 58. Biogen Corporation Information
Table 59. Biogen Description and Business Overview
Table 60. Biogen Dalfampridine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Biogen Dalfampridine Product
Table 62. Biogen Recent Developments/Updates
Table 63. Sun Pharmaceutical Corporation Information
Table 64. Sun Pharmaceutical Description and Business Overview
Table 65. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharmaceutical Dalfampridine Product
Table 67. Sun Pharmaceutical Recent Developments/Updates
Table 68. Aurobindo Pharma Corporation Information
Table 69. Aurobindo Pharma Description and Business Overview
Table 70. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Aurobindo Pharma Dalfampridine Product
Table 72. Aurobindo Pharma Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Dalfampridine Distributors List
Table 76. Dalfampridine Customers List
Table 77. Dalfampridine Market Trends
Table 78. Dalfampridine Growth Drivers
Table 79. Dalfampridine Market Restraints
Table 80. Global Dalfampridine Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Dalfampridine Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Dalfampridine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Dalfampridine Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Dalfampridine Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Dalfampridine Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Dalfampridine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Dalfampridine Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Dalfampridine Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Dalfampridine Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Dalfampridine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Dalfampridine Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dalfampridine
Figure 2. Global Dalfampridine Market Share by Type in 2020 & 2027
Figure 3. 10 mg Product Picture
Figure 4. Others Product Picture
Figure 5. Global Dalfampridine Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Dalfampridine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Dalfampridine Market Size 2016-2027 (US$ Million)
Figure 11. Global Dalfampridine Sales 2016-2027 (K Units)
Figure 12. Global Dalfampridine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Dalfampridine Sales Share by Manufacturers in 2020
Figure 14. Global Dalfampridine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Dalfampridine Players: Market Share by Revenue in 2020
Figure 16. Dalfampridine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Dalfampridine Sales Market Share by Region (2016-2021)
Figure 18. Global Dalfampridine Sales Market Share by Region in 2020
Figure 19. Global Dalfampridine Revenue Market Share by Region (2016-2021)
Figure 20. Global Dalfampridine Revenue Market Share by Region in 2020
Figure 21. U.S. Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Dalfampridine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Dalfampridine by Type (2016-2021)
Figure 46. Sales Market Share of Dalfampridine by Application (2016-2021)
Figure 47. Sales Market Share of Dalfampridine by Application in 2020
Figure 48. Revenue Share of Dalfampridine by Application (2016-2021)
Figure 49. Revenue Share of Dalfampridine by Application in 2020
Figure 50. Manufacturing Cost Structure of Dalfampridine
Figure 51. Manufacturing Process Analysis of Dalfampridine
Figure 52. Dalfampridine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed